Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Harvard Business School
Julphar
Farmers Insurance
McKinsey
Cantor Fitzgerald
Daiichi Sankyo
QuintilesIMS
Cerilliant

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VILAZODONE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Vilazodone Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00285376 Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response Completed Genaissance Pharmaceuticals Phase 3 This study is designed to determine the safety and effectiveness of vilazodone for major depressive disorder and to discover genetic markers associated with response. This study will enroll approximately 400 patients.
NCT00290914 Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder Completed Pharmacology Research Institute Phase 2 The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.
NCT00644358 A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) Completed Forest Laboratories Phase 3 This open label 52-week clinical trial is designed to assess the safety and tolerability of vilazodone and to analyze genetic markers of response to vilazodone in adult patients diagnosed with MDD. This study will enroll approximately 600 patients.
NCT00683592 Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) Completed Forest Laboratories Phase 3 This randomized, double-blind, placebo-controlled, multicenter, 8-week, clinical trial is designed to assess the efficacy and safety of vilazodone and to evaluate genetic biomarkers of treatment response associated with vilazodone use in adult patients diagnosed with MDD by the DSM-IV-TR criteria.
NCT01473381 Safety and Efficacy of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Vilazodone Hydrochloride

Condition Name

Condition Name for Vilazodone Hydrochloride
Intervention Trials
Major Depressive Disorder 13
Generalized Anxiety Disorder 3
Hot Flushes 1
Separation Anxiety Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Vilazodone Hydrochloride
Intervention Trials
Depression 16
Depressive Disorder, Major 15
Depressive Disorder 15
Disease 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Vilazodone Hydrochloride

Trials by Country

Trials by Country for Vilazodone Hydrochloride
Location Trials
United States 226
Ukraine 5
Serbia 4
Canada 4
Germany 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Vilazodone Hydrochloride
Location Trials
California 14
Florida 12
Texas 12
New York 11
Washington 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Vilazodone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Vilazodone Hydrochloride
Clinical Trial Phase Trials
Phase 4 9
Phase 3 10
Phase 2 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Vilazodone Hydrochloride
Clinical Trial Phase Trials
Completed 20
Recruiting 3
Withdrawn 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Vilazodone Hydrochloride

Sponsor Name

Sponsor Name for Vilazodone Hydrochloride
Sponsor Trials
Forest Laboratories 19
National Institute on Drug Abuse (NIDA) 1
University of Chicago 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Vilazodone Hydrochloride
Sponsor Trials
Industry 20
Other 14
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Chubb
Johnson and Johnson
Express Scripts
Citi
Fish and Richardson
Cerilliant
Teva
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.